Active, Not Recruiting
A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression
NCT06939452
- Conditions
- Adenocarcinoma, Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma, Carcinoma, +3 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China